{
    "nctId": "NCT04996615",
    "briefTitle": "Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women",
    "officialTitle": "Peking University People's Hospital Breast Center",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Magnetic Resonance Imaging",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 5000,
    "primaryOutcomeMeasure": "screening yield",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients undergoing full sequence BMRI examination\n* Written informed consent and complete the clinical data questionnaire\n* Through the follow-up database, at least 6 months of follow-up results can be obtained to determine whether the diagnosis result is negative/benign/malignant; for patients who need pathological biopsy, the pathological biopsy results shall prevail to determine the lesion benign/malignant.\n\nExclusion Criteria:\n\n* The breast had received radiotherapy, chemotherapy, biology and other treatments before BMRI.\n* Signs or symptoms of breast disease\n* There are contraindications for breast-enhanced MRI examinations such as allergy to contrast agents.\n* Patients during lactation or pregnancy",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}